Insider: Huntsman Carole Chief Commercial Officer - MADRIGAL PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 12,692 | 0 | 12,692 |
| Value | $6,941,127.88 | $0.00 | $6,941,127.88 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/06/2026 | DDS | 419 | Direct | COM | $431.94 | $180,982.86 | 12,692 |
| 01/26/2026 | DDS | 340 | Direct | COM | $492.42 | $167,422.80 | 9,692 |
| 01/26/2026 | DDS | 570 | Direct | COM | $494.59 | $281,916.30 | 9,122 |
| 11/21/2025 | DDS | 200 | Direct | COM | $552.38 | $110,476.80 | 10,592 |
| 11/21/2025 | DDS | 40 | Direct | COM | $549.34 | $21,973.70 | 10,792 |
| 11/21/2025 | DDS | 894 | Direct | COM | $550.97 | $492,567.18 | 11,096 |
| 11/21/2025 | DDS | 40 | Direct | COM | $553.23 | $22,129.13 | 10,552 |
| 11/21/2025 | DDS | 120 | Direct | COM | $548.71 | $65,845.20 | 10,832 |
| 11/21/2025 | DDS | 144 | Direct | COM | $547.27 | $78,806.64 | 10,952 |
| 11/21/2025 | DDS | 120 | Direct | COM | $556.04 | $66,724.80 | 10,432 |
| 11/21/2025 | DDS | 40 | Direct | COM | $563.21 | $22,528.40 | 10,112 |
| 11/21/2025 | DDS | 80 | Direct | COM | $564.57 | $45,165.20 | 10,032 |
| 11/21/2025 | DDS | 200 | Direct | COM | $559.60 | $111,919.60 | 10,232 |
| 11/21/2025 | DDS | 80 | Direct | COM | $560.62 | $44,849.60 | 10,152 |
| 03/03/2025 | DDS | 300 | Direct | COM | $320.21 | $96,063.00 | 9,867 |
| 03/03/2025 | DDS | 71 | Direct | COM | $313.08 | $22,228.68 | 10,367 |
| 03/03/2025 | DDS | 200 | Direct | COM | $323.65 | $64,730.00 | 9,667 |
| 03/03/2025 | DDS | 200 | Direct | COM | $314.74 | $62,948.00 | 10,167 |
| 03/03/2025 | DDS | 100 | Direct | COM | $327.49 | $32,749.00 | 9,267 |
| 03/03/2025 | DDS | 563 | Direct | COM | $335.00 | $188,605.00 | 8,604 |
| 03/03/2025 | DDS | 200 | Direct | COM | $324.59 | $64,918.00 | 9,467 |
| 03/03/2025 | DDS | 100 | Direct | COM | $329.64 | $32,964.00 | 9,167 |
| 03/03/2025 | DDS | 100 | Direct | COM | $326.34 | $32,634.00 | 9,367 |
| 01/24/2025 | DDS | 347 | Direct | COM | $335.24 | $116,328.28 | 10,438 |
| 11/21/2024 | DDS | 688 | Direct | COM | $316.92 | $218,040.96 | 10,785 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research